Published on in Vol 14 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/73926, first published .
Feasibility, Safety, and Impact of the Probiotics Lactiplantibacillus plantarum and Bifidobacterium longum subspecies infantis in Papua New Guinean Infants: Protocol for a Randomized Controlled Trial

Feasibility, Safety, and Impact of the Probiotics Lactiplantibacillus plantarum and Bifidobacterium longum subspecies infantis in Papua New Guinean Infants: Protocol for a Randomized Controlled Trial

Feasibility, Safety, and Impact of the Probiotics Lactiplantibacillus plantarum and Bifidobacterium longum subspecies infantis in Papua New Guinean Infants: Protocol for a Randomized Controlled Trial

Rebecca L Ford   1 , PhD ;   Andrew R Greenhill   2 , PhD ;   Joycelyn Sapura   1 , DipHS(RH) ;   Amelia Koata   1 , DipN ;   Mary Dreyam   1 , DipN ;   Tilda Orami   1 , BSc ;   Joe Jude   1 , BSc ;   Madeline Ong   3 , MD ;   Wendy Kirarock   1 , BSc ;   Dorcas Joseph   1 , Cert OA ;   Geraldine Masiria   1 , BHS(RH) ;   Celestine Aho   1 , PhD ;   William S Pomat   1 , PhD ;   Anita H J van den Biggelaar   3, 4 , PhD ;   Peter C Richmond   3, 5 , MBBS

1 Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea

2 Microbiology Research Group, Institute of Innovation, Science and Sustainability, Federation University, Churchill, Australia

3 Wesfarmers Centre for Vaccines and Infectious Diseases, The Kids Research Institute Australia, Perth, Australia

4 Centre for Child Health Research, University of Western Australia, Perth, Australia

5 Discipline of Paediatrics, Medical School, University of Western Australia, Perth, Australia

Corresponding Author:

  • Rebecca L Ford, PhD
  • Papua New Guinea Institute of Medical Research
  • PO Box 60
  • Cnr of Homate & Leigh Vial Streets
  • Goroka EHP 441
  • Papua New Guinea
  • Phone: 675 532 2800
  • Fax: 675 532 1998
  • Email: rebecca.ford.imr@gmail.com